A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

2021-02-01

Radiotherapy & Oncology , Volume 155 p. 232- 236

Additional Metadata
Keywords	FOLFIRINOX, locally advanced pancreatic cancer (LAPC), Stereotactic body radiotherapy (SBRT)
Persistent URL	doi.org/10.1016/j.radonc.2020.11.006, hdl.handle.net/1765/132347
Journal	Radiotherapy & Oncology
Organisation	Department of Surgery
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Teriaca, M.A. (M. A.), Loi, M. (M.), Suker, M, Eskens, F.A.L.M, van Eijck, C.H.J, & Nuyttens, J.J.M.E. (2021). A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome. Radiotherapy & Oncology, 155, 232–236. doi:10.1016/j.radonc.2020.11.006

Publication